Author: Talia Ogliore

Yan Yu, a scientist trained in both chemistry and engineering whose research focuses on developing nanotechnologies to detect and treat immune-related diseases, is the inaugural Art Krieg Professor at WashU. Yu gave a talk titled “Breaking Barriers: From Immune Cells to Classrooms.”

WashU Medicine researchers Randall J. Bateman, MD, and David M. Holtzman, MD, were honored for their work developing diagnostic blood tests for Alzheimer’s disease with the Bayh-Dole Coalition’s 2026 American Innovator Award.

A tool developed by WashU Medicine researchers can accurately distinguish among several major neurodegenerative diseases — including Alzheimer’s, Parkinson’s, frontotemporal dementia and dementia with Lewy bodies — as well as detect when these conditions overlap, potentially improving early diagnosis, monitoring and treatment.

Anne M. Drewry, MD, a nationally recognized leader in critical care medicine, has been installed as the inaugural Llorin-Roa Professor of Anesthesiology at WashU Medicine.

Graduate student speaker Sejal Popat, who earned a master’s in fine arts in illustration and visual culture from the WashU Sam Fox School, delivered a message to the Class of 2026 at Washington University in St. Louis during the May 15 Commencement ceremony on Francis Olympic Field.

Emmy Award-winning host, producer and author Andy Cohen delivered a message to the Class of 2026 at Washington University in St. Louis during the May 15 Commencement ceremony on Francis Olympic Field.

A cost-effective screening tool developed by WashU Medicine researchers allows for broader genomic testing for patients with peripheral neuropathy of unknown cause.

A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant helps prevent toxic side effects and potentially improves the effectiveness of therapies.

Six WashU seniors from the Department of BIology in Arts & Sciences and WashU McKelvey Engineering have won annual awards recognizing their achievements.

A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.